# Sinupret Extract Coated Tablets in Chronic Rhinosinusitis

> **NCT02746042** · PHASE3 · COMPLETED · sponsor: **Bionorica SE** · enrollment: 572 (actual)

## Conditions studied

- Chronic Rhinosinusitis

## Interventions

- **DRUG:** Sinupret extract coated tablets
- **DRUG:** Placebo coated tablets

## Key facts

- **NCT ID:** NCT02746042
- **Lead sponsor:** Bionorica SE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-28
- **Primary completion:** 2017-07-26
- **Final completion:** 2017-08-23
- **Target enrollment:** 572 (ACTUAL)
- **Last updated:** 2018-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02746042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02746042, "Sinupret Extract Coated Tablets in Chronic Rhinosinusitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02746042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
